Rising demand of non-invasive & minimally invasive surgery and growing geriatric population play a major role in the growth of the powered surgical instrument market. Furthermore, rise in medical tourism in developing countries is expected to boost the market growth in the coming years.
High prevalence of chronic disease rise in global geriatric population and increase in healthcare expenditure are expected to propel the growth of the global powered surgical instrument market.
The report offers detailed insights on the top investment pockets, market size & estimations, growth factors & opportunities, strategic developments, and competitive landscape. According to the report, the global powered surgical instrument market was pegged at $1.94 billion in 2017 and is expected to garner $2.73 billion by 2025, registering a CAGR of 4.2% through 2025.
Handpieces segment to dominate the market throughout the study period
The handpieces segment held the largest share in 2017, contributing about two-thirds of total market revenue, owing to the growing demand for minimally invasive surgery and rapid adoption of technologically advanced surgical instruments. However, the accessories segment is expected to register the fastest CAGR of 5.1% during the study period, owing to frequent change of surgical and electrical accessories due to occurrence of wear and tear of accessories over time. The power source & controls segment is expected to witness steady growth during the forecast period.
Battery-powered instruments segment to portray fastest growth through 2025
The battery-powered instruments segment is expected to register the fastest CAGR of 4.7% during the forecast period. This is attributed to the fact that battery-powered instruments are coreless, lightweight, efficient, and chargeable that provide comfort during surgery, which have boosted their demand. However, electric instruments segment held the largest share in the market in 2017, contributing about 41% of the total revenue, owing to the low cost of electric surgical handpieces and higher power output compared to pneumatic and battery-powered instruments. Pneumatic instruments segment would exhibit steady growth during the forecast period.
Plastic surgery segment to manifest rapid growth by 2025
The plastic surgery segment is estimated to register the fastest CAGR of 6.2% from 2017 to 2023, owing to the growing demand for cosmetic surgeries, increasing incidence of cancer, and growing age-related surgeries across the globe. However, the orthopedic surgery segment accounted the largest share, contributing about 21% share of the market, owing to increased demand for minimally invasive surgery in orthopedics and rise in geriatric population. The other segments analyzed in the report include neurosurgery, ENT surgery, cardiovascular surgery, cardiothoracic surgery, and others.
North America governs the market in 2017
North America held the largest share in the global powered surgical instrument market, garnering about half of the total revenue in 2017, owing to highly sophisticated healthcare infrastructure and high adoption rate of technologically advanced surgical tools in the region. However, Asia-Pacific region is expected to portray the fastest CAGR of 5.4% during the forecast period, owing to high prevalence of chronic diseases and rise in demand of minimally invasive surgery. The other regions analyzed in the report include Europe and Latin America, Middle East and Africa (LAMEA).
Torchbearers of the market
The key players analyzed in the report include De Soutter Medical Ltd., Peter Brasseler Holdings, LLC, Intrauma S.p.A., GEISTER Medizintechnik GmbH, and Ruijin Medical Instrument & Device Co., Ltd.
According to a new report published by Allied Market Research, titled, "Cancer Pain Market by Type and Application: Global Opportunity Analysis and Industry Forecast, 2018 - 2025," the global cancer pain market was valued at $5,285 million in 2017, and is expected to reach $7,545 million by 2025, growing at a CAGR of 4.5% from 2018 to 2025. Download the Sample Report @ https://www.alliedmarketresearch.com/request-sample/5123?utm_source=Blogger&utm_medium=Niranjan Cancer pain is chronic in nature and is commonly associated with cancer. It results from tissue damage, either due to the disease itself or due to different treatments such as chemotherapy, radiotherapy, or surgery. Cancer pain drugs are expected to exhibit significant market growth during the forecast period due to growth in demand for the drugs, surge in prevalence of cancer across the globe, increase in number of R&D activities to develop ideal cancer pain medications, and rise in the unmet nee...
Surge in usage of wireless monitoring devices and increase in population of aging people across the globe drive the growth of the global patient monitoring devices market. However, high cost associated with patient monitoring devices is anticipated to restrain the market growth. Furthermore, increasing technological advancements are expected to provide new opportunities during the forecast period. The Patient Monitoring Devices Market generated $25.76 billion in 2019, and is estimated to reach $44.86 billion by 2027, registering a CAGR of 4.4% from 2020 to 2027. Based on product type, the cardiac monitoring devices segment contributed to the largest share in 2019, accounting for more than one-fourth of the total share, and is estimated to maintain its dominant position during the forecast period. However, the remote patient monitoring devices segment is estimated to portray the highest CAGR of 6.3% during the forecast period. Based on end-user, the hospitals segment a...
Telemedicine/Telehealth Market to Hit $431.82 Bn, Globally, by 2030 at 25.90% CAGR: Allied Market Research : /PRNewswire/ -- Allied Market Research recently published a report, titled, "Telemedicine market by Application (Teleradiology, Telepsychiatry, Telepathology,...
Comments
Post a Comment